| Literature DB >> 31346580 |
Yoshio Takesue1, Hiroaki Miyata2, Mitsukazu Gotoh1, Go Wakabayashi1, Hiroyuki Konno2, Masaki Mori1, Hiraku Kumamaru1, Takashi Ueda1, Kazuhiko Nakajima1, Motoi Uchino1, Yasuyuki Seto1.
Abstract
BACKGROUND: The aim of the present study was to develop a risk calculator predictive of postoperative pneumonia in patients undergoing gastroenterological surgery.Entities:
Keywords: National Clinical Database; gastroenterological surgery; pneumonia; postoperative complication; risk model
Year: 2019 PMID: 31346580 PMCID: PMC6635692 DOI: 10.1002/ags3.12248
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
Cut‐off values of prolonged surgery and severe intraoperative blood loss in eight selected gastroenterological surgeries
| Surgical procedure | Duration of surgery, 75th percentile (min) | Intraoperative blood loss, 75th percentile (mL) |
|---|---|---|
| Esophagectomy | 573 | 684 |
| Distal gastrectomy | 305 | 323 |
| Total gastrectomy | 338 | 635 |
| Right hemicolectomy | 245 | 246 |
| Low anterior resection | 335 | 375 |
| Hepatectomy with >1 segment except for the lateral segment | 477 | 1570 |
| Pancreaticoduodenectomy | 547 | 1300 |
| Operation for acute diffuse peritonitis | 160 | 247 |
Univariate analysis of risk factors for postoperative pneumonia in 382 124 patients undergoing eight main gastroenterological surgeries between 2011 and 2013 using the NCD in Japan
| Risk factors | No. of patients with postoperative pneumonia (%) | ||
|---|---|---|---|
| Corresponding factor (+) | Corresponding factor (−) |
| |
| Demographics | |||
| Age category (<60, 60‐64, 65‐69, 70‐74, 75‐79, ≥80 y) | – | <0.0001 | |
| Male | 8864/248 341 (3.6%) | 2241/133 783 (1.7%) | <0.0001 |
| Comorbidity | |||
| Chronic obstructive pulmonary disease | 1245/13 166 (9.5%) | 9860/368 958 (2.7%) | <0.0001 |
| Cerebrovascular disease | 1048/13 979 (7.5%) | 10 057/368 145 (2.7%) | <0.0001 |
| Diabetes | 2352/6671 (3.5%) | 8753/315 413 (2.8%) | <0.0001 |
| Ascites | 1018/12 871 (7.9%) | 10 087/369 253 (2.7%) | <0.0001 |
| Hypertension | 4896/132 237 (3.7%) | 6209/249 887 (2.5%) | <0.0001 |
| Congestive heart failure | 320/3369 (9.5%) | 10 785/378 755 (2.8%) | <0.0001 |
| Myocardial infarction | 125/2101 (5.9%) | 10 980/380 023 (2.9%) | <0.0001 |
| Angina | 246/5095 (4.8%) | 10 859/377 029 (2.9%) | <0.0001 |
| Peripheral vascular disease | 136/1365 (10.0%) | 10 969/380 759 (2.9%) | <0.0001 |
| Hemodialysis | 239/3564 (6.7%) | 10 866/378 560 (2.9%) | <0.0001 |
| Bleeding disorder | 1129/15 090 (7.5%) | 9976/367 034 (2.7%) | <0.0001 |
| ASA Physical Status classification >grade 2 | 3549/50 276 (7.1%) | 7566/331 848 (2.3%) | <0.0001 |
| Medical history | |||
| Previous cardiac surgery | 266/4354 (6.1%) | 10 839/377 770 (2.9%) | <0.0001 |
| Previous percutaneous coronary intervention | 532/8906 (6.0%) | 10 573/373 218 (2.8%) | <0.0001 |
| Chronic steroid use | 309/3950 (7.8%) | 10 796/378 174 (2.9%) | <0.0001 |
| Preoperative chemotherapy | 692/11 627 (6.0%) | 10 413/370 497 (2.8%) | <0.0001 |
| Preoperative radiotherapy | 204/3381 (6.0%) | 10 901/378 743 (2.9%) | <0.0001 |
| Lifestyle, activity | |||
| ADL need for any assistance | 2505/25 384 (9.7%) | 8600/356 290 (2.4%) | <0.0001 |
| Tobacco use, Brinkman index >400 | 4635/109 161 (4.2%) | 6470/272 963 (2.4%) | <0.0001 |
| Alcohol habitually | 3525/97 146 (3.6%) | 7580/284 978 (2.7%) | <0.0001 |
| Preoperative particular condition | |||
| Body weight loss >10% | 1182/20 154 (5.9%) | 9923/361 970 (2.7%) | <0.0001 |
| Preoperative transfusions | 676/10 387 (6.5%) | 10 429/371 737 (2.8%) | <0.0001 |
| Disseminated cancer | 534/11 954 (4.5%) | 10 571/370 170 (2.9%) | <0.0001 |
| SIRS with infection | 1322/9798 (13.5%) | 9783/372 326 (2.6%) | <0.0001 |
| Emergent surgery | 2410/35 199 (6.8%) | 8695/346 925 (2.5%) | <0.0001 |
| Preoperative ventilation | 214/1491 (14.4%) | 10 891/380 633 (2.9%) | <0.0001 |
| Primary disease | |||
| Gastric cancer | 4233/164 858 (2.6%) | 6872/217 266 (3.2%) | <0.001 |
| Cholangiocarcinoma (extrahepatic bile ducts perihilar) | 75/1838 (4.1%) | 11 030/380 286 (2.9%) | 0.0031 |
| Cholangiocarcinoma (extrahepatic bile ducts distal) | 204/5817 (3.5%) | 10 901/376 307 (2.9%) | 0.0067 |
| Gallbladder cancer | 49/1198 (4.1%) | 11 056/380 926 (2.9%) | 0.0163 |
| No tumor | 2073/34 530 (6.0%) | 9032/347 594 (2.6%) | <0.001 |
| Primary surgery | |||
| Operation for acute diffuse peritonitis (JSGS15) | 2045/27 377 (7.5%) | 9060/354 747 (2.6%) | <0.001 |
| Hepatectomy with >1 segment except for the lateral segment (JSGS39) | 515/23 610 (2.2%) | 10 590/358 514 (3.0%) | <0.001 |
| Pancreaticoduodenectomy (JSGS91) | 692/27 702 (2.5%) | 10 413/354 422 (2.9%) | <0.001 |
| Esophagectomy (JSGS103) | 2268/16 556 (13.7%) | 8837/365 568 (2.4%) | <0.001 |
| Low anterior resection (JSGS 3) | 524/58 401 (0.9%) | 10 581/323 723 (3.3%) | <0.001 |
| Right hemicolectomy (JSGS 31) | 1000/60 738 (1.6%) | 10 105/321 386 (3.1%) | <0.001 |
| Total gastrectomy (JSGS47) | 2105/58 809 (3.6%) | 9000/323 315 (2.8%) | <0.001 |
| Distal gastrectomy (JSGS49) | 2192/112 867 (1.9%) | 8913/269 257 (3.3%) | <0.001 |
| Associated surgery | |||
| Splenectomy (JSGS69) | 225/5873 (3.8%) | 10 880/376 251 (2.9%) | <0.001 |
| Enterostomy/closure with bowel resection (JSGS73) | 353/5640 (6.3%) | 10 752/376 484 (2.9%) | <0.001 |
| Enterostomy/closure without bowel resection (JSGS74) | 685/10 066 (6.8%) | 10 420/372 058 (2.8%) | <0.001 |
| Preoperative laboratory examination | |||
| Albumin <2.5 g/dL | 1283/13 542 (9.5%) | 9822/368 582 (2.7%) | <0.001 |
| AST >35 IU/L | 2100/48 875 (4.3%) | 9005/333 249 (2.7%) | <0.001 |
| ALP >340 IU/L | 1877/48 829 (3.8%) | 9228/333 295 (2.8%) | <0.001 |
| BUN >25 mg/dL | 2103/27 217 (7.7%) | 9002/354 907 (2.5%) | <0.001 |
| Na <138 mEq/dL | 2636/48 885 (5.4%) | 8469/333 239 (2.5%) | <0.001 |
| Creatinine >3 mg/dL | 396/5575 (7.1%) | 10 709/376 549 (2.8%) | <0.001 |
| Hematocrit <21% | 150/2886 (5.2%) | 10 955/379 238 (2.9%) | <0.001 |
| Hematocrit: male >48%, female >42% | 234/101 866 (2.3%) | 10 871/371 938 (2.9%) | 0.002 |
| Total bilirubin >3 mg/dL | 275/6210 (4.4%) | 10 830/375 914 (2.9%) | <0.001 |
| C‐reactive protein >10 mg/dL | 1401/17 665 (7.9%) | 9704/364 459 (2.7%) | <0.001 |
| White blood cell count <3500/μL | 1025/23 487 (4.4%) | 10 090/358 637 (2.8%) | <0.001 |
| White blood cell count >12 000/μL | 945/16 817 (5.6%) | 10 160/365 307 (2.8%) | <0.001 |
| Platelet count <15 × 104/μL | 1695/32 917 (5.1%) | 9410/349 207 (2.7%) | <0.001 |
| Prothrombin time‐INR >1.1 | 2742/51 603 (5.3%) | 8363/330 521 (2.5%) | <0.001 |
| Intraoperative factors | |||
| Prolonged surgery (>75th percentile) | 3706/95 328 (3.9%) | 7399/286 796 (2.6%) | <0.001 |
| Severe blood loss (>75th percentile) | 4319/94 332 (4.6%) | 6786/287 792 (2.4%) | <0.001 |
ADL, activities of daily living; ALP, alkaline phosphatase; ASA, American Society of Anesthesiologists; AST, aspartate aminotransferase; BUN, blood urea nitrogen; INR, international normalized ratio; NCD, National Clinical Database; SIRS, systemic inflammatory response syndrome.
Multivariate logistic regression model of risk factors for postoperative pneumonia in 247 604 patients between 2011 and 2012 using the NCD in Japan
| Risk factors | Multivariate analysis | ||||
|---|---|---|---|---|---|
| Adjusted odds ratio | 95% CI |
| β coefficient | ||
| Lower | Upper | ||||
| Demographics | |||||
| Age category | 1.293 | 1.272 | 1.314 | <0.001 | 0.257 |
| Male | 1.740 | 1.632 | 1.856 | <0.001 | 0.554 |
| Comorbidity | |||||
| Chronic obstructive pulmonary disease | 2.041 | 1.877 | 2.219 | <0.001 | 0.713 |
| Cerebrovascular disease | 1.607 | 1.469 | 1.758 | <0.001 | 0.474 |
| Diabetes | 1.073 | 1.009 | 1.140 | 0.024 | 0.070 |
| Ascites | 1.123 | 1.014 | 1.244 | 0.026 | 0.116 |
| Hypertension | 1.114 | 1.059 | 1.172 | <0.001 | 0.108 |
| Bleeding disorder | 1.129 | 1.030 | 1.237 | 0.010 | 0.121 |
| ASA >grade 2 | 1.417 | 1.329 | 1.511 | <0.001 | 0.348 |
| Medical history | |||||
| Previous percutaneous coronary intervention | 1.301 | 1.154 | 1.467 | <0.001 | 0.263 |
| Chronic steroid use | 1.626 | 1.391 | 1.901 | <0.001 | 0.486 |
| Lifestyle, activity | |||||
| ADL need for any assistance | 2.066 | 1.921 | 2.222 | <0.001 | 0.726 |
| Tobacco use, Brinkman index >400 | 1.305 | 1.236 | 1.379 | <0.001 | 0.266 |
| Preoperative particular condition | |||||
| Body weight loss >10% | 1.286 | 1.183 | 1.397 | <0.001 | 0.251 |
| Preoperative transfusions | 1.204 | 1.079 | 1.343 | 0.001 | 0.185 |
| SIRS with infection | 1.777 | 1.594 | 1.981 | <0.001 | 0.575 |
| Emergent surgery | 1.609 | 1.423 | 1.818 | <0.001 | 0.476 |
| Disseminated cancer | 1.187 | 1.056 | 1.333 | 0.004 | 0.171 |
| Primary disease | |||||
| Gastric cancer (total/distal gastrectomy, JSGS47, 49) | 1.843 | 1.722 | 1.973 | <0.001 | 0.612 |
| Cancer of small intestine | 1.606 | 1.163 | 2.218 | 0.004 | 0.474 |
| Cholangiocarcinoma (extrahepatic bile ducts perihilar) | 1.655 | 1.255 | 2.184 | <0.001 | 0.504 |
| Cholangiocarcinoma (extrahepatic bile ducts distal) | 1.284 | 1.043 | 1.580 | 0.018 | 0.250 |
| Gallbladder cancer | 1.655 | 1.165 | 2.351 | 0.005 | 0.504 |
| Primary surgery | |||||
| Operation for acute diffuse peritonitis (JSGS15) | 1.740 | 1.524 | 1.986 | <0.001 | 0.554 |
| Hepatectomy with >1 segment except for lateral segment (JSGS39) | 1.700 | 1.499 | 1.927 | <0.001 | 0.530 |
| Pancreaticoduodenectomy (JSGS91) | 1.809 | 1.590 | 2.057 | <0.001 | 0.593 |
| Esophagectomy (JSGS103) | 13.727 | 12.640 | 14.907 | <0.001 | 2.619 |
| Associated surgery | |||||
| Splenectomy (JSGS69) | 1.363 | 1.138 | 1.632 | 0.001 | 0.310 |
| Enterostomy/closure with bowel resection (JSGS73) | 1.279 | 1.094 | 1.495 | 0.002 | 0.246 |
| Enterostomy/closure without bowel resection (JSGS74) | 1.228 | 1.097 | 1.375 | <0.001 | 0.206 |
| Preoperative laboratory examination | |||||
| Hematocrit: male >48%, female >42% | 1.178 | 1.006 | 1.379 | 0.042 | 0.164 |
| Albumin <2.5 g/dL | 1.365 | 1.244 | 1.498 | <0.001 | 0.311 |
| AST >35 IU/L | 1.130 | 1.056 | 1.210 | <0.001 | 0.123 |
| ALP >340 IU/L | 1.146 | 1.066 | 1.232 | <0.001 | 0.136 |
| BUN >25 mg/dL | 1.232 | 1.145 | 1.325 | <0.001 | 0.208 |
| Na <138 mEq/dL | 1.168 | 1.098 | 1.241 | <0.001 | 0.155 |
| Intraoperative factors | |||||
| Prolonged surgery (>75th percentile) | 1.368 | 1.295 | 1.444 | <0.001 | 0.313 |
| Severe blood loss (>75th percentile) | 1.461 | 1.387 | 1.539 | <0.001 | 0.379 |
95% CI, 95% confidence interval; ADL, activities of daily living; ALP, alkaline phosphatase; ASA, American Society of Anesthesiologists; AST, aspartate aminotransferase; BUN, blood urea nitrogen; NCD, National Clinical Database; SIRS, systemic inflammatory response syndrome.
Calculation of risk score of primary diagnosis and surgical procedures
| Risk factors |
| β | |
|---|---|---|---|
| Yes | No | ||
| 1. Disseminated cancer | 1 | 0 | 0.171 |
| 2. Gastric cancer | 1 | 0 | 0.612 |
| 3. Cancer of small intestine | 1 | 0 | 0.474 |
| 4. Cholangiocarcinoma (extrahepatic bile ducts perihilar) | 1 | 0 | 0.504 |
| 5. Cholangiocarcinoma (extrahepatic bile ducts distal) | 1 | 0 | 0.250 |
| 6. Gallbladder cancer | 1 | 0 | 0.504 |
| 7. Operation for acute diffuse peritonitis | 1 | 0 | 0.554 |
| 8. Hepatectomy with >1 segment except for lateral segment | 1 | 0 | 0.530 |
| 9. Pancreaticoduodenectomy | 1 | 0 | 0.593 |
| 10. Esophagectomy | 1 | 0 | 2.619 |
| 11. Splenectomy | 1 | 0 | 0.310 |
| 12. Enterostomy/closure with bowel resection | 1 | 0 | 0.246 |
| 13. Enterostomy/closure without bowel resection | 1 | 0 | 0.206 |
Risk score of primary diagnosis and surgical procedures, Σ [β × X ].
β is the coefficient of the variable X in the logistic regression equation. If a categorical risk factor is present, the X value is 1 (0 if it is absent). A total risk score of primary diagnosis and surgical procedures for a given patient is calculated by summing β × X .
Calculation of the total risk score
| Risk factors |
| β | |
|---|---|---|---|
| Yes | No | ||
| Patient characteristics | |||
| 1. Age category, y | <60 = 1, 60‐64 = 2, 65‐69 = 3, 70‐74 = 4, 75‐79 = 5, ≥80 = 6 | 0.257 | |
| 2. Male | 1 | 0 | 0.554 |
| 3. Chronic obstructive pulmonary disease | 1 | 0 | 0.713 |
| 4. Cerebrovascular disease | 1 | 0 | 0.474 |
| 5. Diabetes | 1 | 0 | 0.070 |
| 6. Ascites | 1 | 0 | 0.116 |
| 7. Hypertension | 1 | 0 | 0.108 |
| 8. Bleeding disorder | 1 | 0 | 0.121 |
| 9. ASA >grade 2 | 1 | 0 | 0.348 |
| 10. Previous percutaneous coronary intervention | 1 | 0 | 0.263 |
| 11. Chronic steroid use | 1 | 0 | 0.486 |
| 12. ADL need for any assistance | 1 | 0 | 0.726 |
| 13. Tobacco use, Brinkman index >400 | 1 | 0 | 0.266 |
| 14. Body weight loss >10% | 1 | 0 | 0.251 |
| 15. Preoperative transfusions | 1 | 0 | 0.185 |
| 16. SIRS with infection | 1 | 0 | 0.575 |
| 17. Emergent surgery | 1 | 0 | 0.476 |
| Preoperative laboratory data | |||
| 1. Hematocrit: male >48%, female >42% | 1 | 0 | 0.164 |
| 2. Albumin <2.5 g/dL | 1 | 0 | 0.311 |
| 3. AST >35 IU/L | 1 | 0 | 0.123 |
| 4. ALP >340 IU/L | 1 | 0 | 0.136 |
| 5. BUN >25 mg/dL | 1 | 0 | 0.208 |
| 6. Na <138 mEq/dL | 1 | 0 | 0.155 |
| Intraoperative factors | |||
| 1. Prolonged surgery (>75th percentile) | 1 | 0 | 0.313 |
| 2. Severe blood loss (>75th percentile) | 1 | 0 | 0.379 |
Risk score of patients' characteristics, laboratory data and intraoperative factors, Σ [β × X ].
Total risk score = risk score of primary diagnosis and surgical procedures + risk score of patients' characteristics, laboratory data and intraoperative factors.
β is the coefficient of the variable X in the logistic regression equation. If a categorical risk factor is present, the X value is 1 (0 if it is absent). For the age categories, X is defined according to the definition. Total risk score for a given patient is calculated by summing β × X .
ADL, activities of daily living; ALP, alkaline phosphatase; ASA, American Society of Anesthesiologists; AST, aspartate aminotransferase; BUN, blood urea nitrogen; SIRS, systemic inflammatory response syndrome.
Figure 1Approximated predicted risk for postoperative pneumonia. Risk for postoperative pneumonia is approximated from a nomogram of predicted probability vs calculated total risk score. βi is the coefficient of the variable Xi in the logistic regression equation provided in Table 4
Figure 2Receiver‐operating characteristic (ROC) curve for postoperative pneumonia in the derivation and validation groups. Area under the ROC curve was 0.822 (95% CI, 0.817‐0.826) in the derivation subset of the study sample and 0.826 (95% CI, 0.819‐0.832) in the validation subset of the study sample
Figure 3Calibration of the postoperative pneumonia model. Bar charts represent mean rate for the predicted events. Line chart represents those for the observed events, and the error bars represent 95% CI of the observed events. The risk score is calculated using Σ [β × X ]. βi is the coefficient of the variable Xi in the logistic regression equation. This figure represents how well the rates of the predicted events matched those of the observed events according to the patient risk subgroups